EMA To Draw Up 'Critical Medicine' Lists For Future Health Crises
Industry Will Be ‘Invited’ To Review Product Lists
Executive Summary
As part of its expanded mandate, the EU regulator is identifying those medicines whose supply will need to be closely monitored during health crisis situations. The lists will draw on various information sources, including real-world evidence databases.
You may also be interested in...
Bigger Trials, More RWE Needed for Future Crisis Response, Say EU Regulators
A report from the EU medicines regulatory network looks at what was done well in the response to the COVID-19 pandemic, and what needs to be improved if we are to be better prepared next time.
French Industry Chief On How To Encourage Innovation & Avoid Drug Shortages
Pricing challenges, high taxes and the growing problem of drug shortages have led the pharmaceutical industry body Leem to come forward with a set of proposals that it says should inform future government policy towards the sector.
EU Health Crisis Package Includes Supply Chain Revamps, Central Procurement & Regulatory Flexibility
The European Commission says that all the legislation for the creation of the European Health Union is now in place, following the publication of regulations on the supply and availability of medical countermeasures, centrally coordinated procurement mechanisms, and “ever-ready” manufacturing capacity for use in health emergencies.